Elevated Circulating IGF-I Promotes Mammary Gland Development and Proliferation

Endocrinology

Volumn 151, Issue 12, 2010, Pages 5751-5761

  Cannata, Dara ^a   Lann, Danielle ^a   Wu, Yingjie ^a   Elis, Sebastien ^a   Sun, Hui ^a   Yakar, Shoshana ^a   Lazzarino, Deborah A ^b   Wood, Teresa L ^b   LeRoith, Derek ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; MOUSE; MYOEPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

AGING; ANIMALS; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INSULIN-LIKE GROWTH FACTOR I; MAMMARY GLANDS, ANIMAL; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; ORGAN SIZE; PHOSPHORYLATION; RATS; WEIGHT GAIN;

EID: 78649892480     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0792     Document Type: Article

References (35)

1. Richert MM, Schwertfeger KL, Ryder JW, Anderson SM 2000 An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 5:227-241
2. Kleinberg DL, Wood TL, Furth PA, Lee AV 2009 Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. Endocr Rev 30:51-74
3. Kleinberg DL 1998 Role of IGF-I in normal mammary development. Breast Cancer Res Treat 47:201-208
4. Wood TL, Richert MM, Stull MA, Allar MA 2000 The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands. J Mammary Gland Biol Neoplasia 5:31-42
5. LeRoith D, Neuenschwander S, Wood TL, Hennighausen L 1995 Insulin-like growth factor-I and insulin-like growth factor binding protein-3 inhibit involution of the mammary gland following lactation: studies in transgenic mice. Prog Growth Factor Res 6:433-436
6. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74
7. Ruan W, Kleinberg DL 1999 Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 140:5075-5081
8. Kleinberg DL, Ruan W 2008 IGF-I, GH, and sex steroid effects in normal mammary gland development. J Mammary Gland Biol Neoplasia 13:353-360
9. Richert MM, Wood TL 1999 The insulin-like growth factors (IGF) and IGF type I receptor during postnatal growth of the murine mammary gland: sites of messenger ribonucleic acid expression and potential functions. Endocrinology 140:454-461
10. Walden PD, Ruan W, Feldman M, Kleinberg DL 1998 Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development. Endocrinology 139:659-662
11. Weber MS, Boyle PL, Corl BA, Wong EA, Gwazdauskas FC, Akers RM 1998 Expression of ovine insulin-like growth factor-1 (IGF-1) stimulates alveolar bud development in mammary glands of transgenic mice. Endocrine 8:251-259
12. Hadsell DL, Greenberg NM, Fligger JM, Baumrucker CR, Rosen JM 1996 Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology 137:321-330
13. Hadsell DL, Torres DT, Lawrence NA, George J, Parlow AF, Lee AV, Fiorotto ML 2005 Overexpression of des(1-3) insulin-like growth factor 1 in themammaryglands of transgenic mice delays the loss of milk production with prolonged lactation. Biol Reprod 73:1116-1125
14. Neuenschwander S, Schwartz A, Wood TL, Roberts Jr CT, Hennighausen L, LeRoith D 1996 Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest 97:2225-2232
15. Loladze AV, Stull MA, Rowzee AM, Demarco J, Lantry 3rd JH, Rosen CJ, Leroith D, Wagner KU, Hennighausen L, Wood TL 2006 Epithelial-specific and stage-specific functions of insulin-like growth factor-I during postnatal mammary development. Endocrinology 147:5412-5423
16. Richards RG, Klotz DM, Walker MP, Diaugustine RP 2004 Mammary gland branching morphogenesis is diminished in mice with a deficiency of insulin-like growth factor-I (IGF-I), but not in mice with a liver-specific deletion of IGF-I. Endocrinology 145:3106-3110
17. Wu Y, Sun H, Yakar S, LeRoith D 2009 Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice. Endocrinology 150:4395-4403
18. Novosyadlyy R, Lann DE, Vijayakumar A, Rowzee A, Lazzarino DA, Fierz Y, Carboni JM, Gottardis MM, Pennisi PA, Molinolo AA, Kurshan N, Mejia W, Santopietro S, Yakar S, Wood TL, LeRoith D 2010 Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res 70:741-751
19. Elis S, Courtland HW, Wu Y, Rosen CJ, Sun H, Jepsen KJ, Majeska RJ, Yakar S 2010 Elevated serum levels of IGF-1 are sufficient to establish normal body size and skeletal properties even in the absence of tissue IGF-1. J Bone Miner Res 25:1257-1266
20. Pollak MN, Polychronakos C, Yousefi S, Richard M 1988 Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells. Biochem Biophys Res Commun 154:326-331
21. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D 1999 Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 13:787-796
22. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J, Demaille A 1993 Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A:492-497
23. Bruning PF, Van Doorn J, Bonfrèr JM, Van Noord PA, Korse CM, Linders TC, Hart AA 1995 Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 62:266-270
24. Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS 1998 Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9:570-573
25. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396 (Pubitemid 28209997)
26. Polyak K, Hu M 2005 Do myoepithelial cells hold the key for breast tumor progression? J Mammary Gland Biol Neoplasia 10:231-247
27. Gudjonsson T, Adriance MC, Sternlicht MD, Petersen OW, Bissell MJ 2005 Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia. J Mammary Gland Biol Neoplasia 10:261-272
28. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S, Barsky SH 1997 The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 3:1949-1958
29. Sternlicht MD, Barsky SH 1997 The myoepithelial defense: a host defense against cancer. Med Hypotheses 48:37-46
30. Deugnier MA, Teulière J, Faraldo MM, Thiery JP, Glukhova MA 2002 The importance of being a myoepithelial cell. Breast Cancer Res 4:224-230
31. Lakhani SR, O'Hare MJ 2001 The mammary myoepithelial cell- Cinderella or ugly sister? Breast Cancer Res 3:1-4
32. Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC, Gelman RS, Allred C, Bissell MJ, Schnitt S, Polyak K 2008 Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 13:394-406
33. Bonnette SG, Hadsell DL 2001 Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology 142:4937-4945
34. Lee AV, Taylor ST, Greenall J, Mills JD, Tonge DW, Zhang P, George J, Fiorotto ML, Hadsell DL 2003 Rapid induction of IGF-IR signaling in normal and tumor tissue following intravenous injection of IGF-I in mice. Horm Metab Res 35:651-655
35. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ 2009 Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15:907-913